Advertisement

Topics

FDA Approves Higher Vial Strengths for Hemophilia A Drug

18:08 EDT 24 Aug 2017 | PharmPro

Octapharma USA announces FDA approval of Nuwiq new product strengths, expanding hemophilia A patient treatment options. New higher vial strengths will provide added dosing flexibility and convenience.
Contributed Author: 
Octapharma USA
Topics: 

Original Article: FDA Approves Higher Vial Strengths for Hemophilia A Drug

NEXT ARTICLE

More From BioPortfolio on "FDA Approves Higher Vial Strengths for Hemophilia A Drug"

Advertisement
Quick Search
Advertisement
Advertisement